Publications by authors named "Angeliki Befon"
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.
Natalia Rompoti Theognosia Vergou Irene Stefanaki Charitomeni Vavouli Ioannis-Alexios Koumprentziotis Angeliki Befon
Int J Dermatol
October 2024
Article Synopsis
- - Recent studies suggest a potential link between low serum 25-hydroxyvitamin D levels and a higher incidence of cutaneous malignant melanoma (CMM), indicating worse outcomes for patients with such deficiencies.
- - The research analyzed 99 melanoma patients and 97 healthy controls, measuring their serum vitamin D levels and comparing various risk factors and characteristics related to CMM.
- - Although melanoma patients had lower vitamin D levels than healthy controls, the difference did not achieve statistical significance, and no significant associations with cancer severity or characteristics were found.
Article Synopsis
- Imiquimod 3.75% is a topical treatment for actinic keratosis designed to target both visible and hidden lesions on sun-exposed skin, showing effective results in a trial with 15 patients in Greece.* -
- In the study, patients underwent two 2-week treatment cycles with monitoring of lesion counts, which showed an increase in lesions during treatment followed by a significant decrease two weeks after the second cycle.* -
- At the end of the treatment, patients experienced an average reduction of 87% in actinic keratosis lesions, and any mild skin reactions tended to resolve quickly, indicating the treatment was well-tolerated.*
Treatment of alopecia areata remains unsatisfactory. We decided to test if systemic therapy with inosiplex (Isoprinosine(R)), an immunomodulator could influence the disease. Thirty-two subjects with recalcitrant alopecia areata, aged 16-48 years (mean 30.
View Article and Find Full Text PDF